🧬 ICD-10 CM I69.992 — Facial Weakness Following Unspecified Cerebrovascular Disease
Billable Code Confirmed
ICD-10 CM I69.992 is a fully billable, 7-character ICD-10-CM code valid for FY2026 under the I69 Sequelae of Cerebrovascular Disease category. The sixth character “9” indicates “other sequelae of unspecified cerebrovascular disease,” and the seventh character “2” specifies facial weakness as the deficit type. This code is appropriate when the clinician documents facial weakness as a direct sequela of a prior cerebrovascular event but does not specify the type (e.g., hemorrhagic vs. ischemic).
Non-Billable Parent Codes
I69 (Sequelae of cerebrovascular disease) is a non-billable category header requiring additional characters to reach a valid code — it cannot be submitted on a claim. I69.9 (Sequelae of unspecified cerebrovascular diseases) is also non-billable and serves as the subcategory block, requiring further specificity through 5th, 6th, and 7th characters. I69.99 (Other sequelae of unspecified cerebrovascular disease) is the 5-character non-billable subcategory parent of I69.992 and similarly cannot stand alone on a claim.
Clinical Context
This code is selected specifically when the type of cerebrovascular disease (e.g., infarction, hemorrhage, TIA) is not documented or cannot be determined from the medical record. If the underlying event is documented as a cerebral infarction, I69.392 (Facial weakness following cerebral infarction) must be used instead. Clinical documentation should explicitly link the facial weakness to the prior cerebrovascular event to support coding from category I69 rather than assigning an unspecified symptom code such as R29.810.
Code Classification
ICD-10 CM I69.992 is a diagnosis code (ICD-10-CM) representing a late effect/sequela — it is not a procedure code and has no CPT or ICD-10-PCS equivalent. This code classifies facial weakness as a neurological sequela and must be supported by physician documentation establishing a causal relationship between the cerebrovascular event and the current facial deficit.
🔍 Code Description
ICD-10 CM I69.992 captures facial weakness — including facial droop, reduced facial muscle tone, or peripheral facial paresis — documented as a direct consequence of a prior cerebrovascular event when the type of that event is not specified. The I69 category follows ICD-10-CM Guideline I.C.9.d, which instructs coders to assign sequelae codes for neurological deficits persisting after the acute phase of cerebrovascular disease, and these deficits may be present from onset or arise at any point following the initial event. Unlike a new acute neurological event, sequelae codes do not require a specific time interval to have passed — the deficit simply must be documented as a consequence of the prior event. Coders should differentiate this from Bell’s palsy (G51.0) or other primary facial nerve conditions, which have entirely separate etiologies unrelated to cerebrovascular disease.
The “unspecified cerebrovascular disease” qualifier in I69.992 places this code at the bottom of the specificity ladder within the I69 family and should prompt a CDI query whenever possible to determine the original CVA type. If records confirm a prior ischemic stroke, the correct code becomes I69.392; for intracerebral hemorrhage sequelae, I69.192 applies; for subarachnoid hemorrhage, I69.092 is correct. Facial weakness as a sequela is clinically relevant because it affects speech, swallowing, oral hygiene, and patient quality of life, and it may overlap with dysphagia documentation that could justify additional coding. Accurate code assignment from the I69.x92 family ensures proper risk stratification, HCC capture, and DRG grouping.
🌳 Code Tree / Hierarchy
I69 Sequelae of cerebrovascular disease ❌ Non-billable
│
├── I69.0 Sequelae of nontraumatic subarachnoid hemorrhage ❌ Non-billable
│ └── I69.092 Facial weakness following nontraumatic subarachnoid hemorrhage ✅ Billable
│
├── I69.1 Sequelae of nontraumatic intracerebral hemorrhage ❌ Non-billable
│ └── I69.192 Facial weakness following nontraumatic intracerebral hemorrhage ✅ Billable
│
├── I69.3 Sequelae of cerebral infarction ❌ Non-billable
│ └── I69.392 Facial weakness following cerebral infarction ✅ Billable
│
├── I69.8 Sequelae of other cerebrovascular diseases ❌ Non-billable
│ └── I69.892 Facial weakness following other cerebrovascular disease ✅ Billable
│
└── I69.9 Sequelae of unspecified cerebrovascular diseases ❌ Non-billable
│
└── I69.99 Other sequelae of unspecified cerebrovascular disease ❌ Non-billable
│
├── I69.990 Apraxia following unspecified cerebrovascular disease ✅ Billable
├── I69.991 Dysphagia following unspecified cerebrovascular disease ✅ Billable
├── I69.992 Facial weakness following unspecified cerebrovascular disease ◀ THIS CODE ✅ Billable
├── I69.993 Ataxia following unspecified cerebrovascular disease ✅ Billable
└── I69.998 Other sequelae following unspecified cerebrovascular disease ✅ Billable
Why I69.992 Over I69.998?
ICD-10 CM I69.992 is specific to facial weakness and should always be used when that is the documented deficit — I69.998 is a catch-all “other” code that should only be used when the specific deficit type does not have its own dedicated code in the I69.99x family. Payers and auditors will flag I69.998 when a more specific code like I69.992 clearly applies, which could trigger a medical necessity or coding accuracy audit.
Tip
When facial weakness is documented alongside dysphagia following the same unspecified CVA, both I69.991 and I69.992 may be reported together — they are not mutually exclusive. This combination is clinically common in post-stroke patients and can support medical necessity for speech-language pathology services and inpatient rehabilitation placement.
✅ Includes
- Facial droop following prior cerebrovascular event, type unspecified — coded here when facial muscle weakness is explicitly linked in the documentation to a prior CVA without specification of hemorrhagic or ischemic type.
- Peripheral facial paresis as sequela of unspecified CVA — distinct from Bell’s palsy (G51.0) and must be documented as cerebrovascular in origin rather than idiopathic or infectious.
- Post-stroke facial asymmetry documented as residual deficit — applicable when imaging or clinical documentation confirms the asymmetry is a late effect of prior cerebrovascular disease, type unspecified.
❌ Excludes
Excludes 1
ICD-10 CM I69.392 — Facial weakness following cerebral infarction — this is an Excludes 1 relationship, meaning I69.992 and I69.392 cannot be coded together for the same episode; if the underlying CVA is documented as an infarction, I69.392 must be used exclusively. This is the most common specificity error seen in I69.99x coding — coders default to “unspecified” when infarction is actually documented in the history. S06.- — Sequelae of traumatic intracranial injury — if the facial weakness follows a traumatic brain injury rather than a spontaneous cerebrovascular event, the I69 category is excluded entirely and codes from S06.- with the appropriate sequela 7th character apply instead.
Danger
The most dangerous Excludes 1 error with I69.992 is assigning it when the medical record clearly documents “history of ischemic stroke” or “cerebral infarction” — in that scenario, I69.392 is required and I69.992 is incorrect. This error can trigger payer denials, RAC audit flags, and HCC invalidation. Always review the H&P, discharge summary, and any imaging reports before defaulting to the “unspecified” cerebrovascular disease qualifier.
Excludes 2
ICD-10 CM Z86.73 — Personal history of cerebral infarction without residual deficit — this code can be assigned separately when the patient had a prior infarction that has fully resolved with no remaining deficits; it is not mutually exclusive with I69.992 because they represent different clinical states (resolved vs. active residual). G51.0 — Bell’s palsy — may be coded separately when the facial weakness has an idiopathic peripheral etiology confirmed to be independent of any cerebrovascular history, though this dual coding scenario is clinically uncommon and requires clear physician documentation distinguishing the two conditions.
📋 Clinical Overview
Differentiating I69.99x Sequelae Codes
The I69.99x family covers a range of neurological deficits following unspecified cerebrovascular disease, and accurate code selection within this family depends entirely on the type of deficit documented. The most common deficits encountered in the inpatient setting are dysphagia (I69.991), facial weakness (I69.992), and ataxia (I69.993), and all three may co-exist in the same patient following a single cerebrovascular event. CDI specialists should monitor for documentation that references “weakness of the face” or “facial droop” attributed to a prior CVA without specifying whether the CVA was hemorrhagic or ischemic, as this triggers the unspecified pathway. When the original CVA type is known, specificity coding from I69.0x2, I69.1x2, or I69.3x2 families is mandatory.
| Feature | I69.992 | I69.392 | I69.892 |
|---|---|---|---|
| Underlying CVA Type | Unspecified — type of CVD not documented or unknown | Cerebral infarction (ischemic stroke) explicitly documented | Other specified cerebrovascular disease (e.g., CADASIL, AVM) |
| Deficit Type | Facial weakness / facial droop / peripheral facial paresis | Facial weakness / facial droop / peripheral facial paresis | Facial weakness / facial droop / peripheral facial paresis |
| Code Specificity | Lowest specificity — use only when CVA type genuinely unspecified | Higher specificity — preferred when infarction is documented | Moderate specificity — for named non-infarct, non-hemorrhagic CVD |
| HCC Impact | Supports HCC capture when etiology documented as CVA | Stronger HCC support with confirmed ischemic etiology | HCC support depends on underlying disease mapping |
| CDI Priority | High — query for original CVA type to improve specificity | Optimal — no further query needed if infarction confirmed | Moderate — query for specific CVD diagnosis if possible |
Important
Any documentation of “facial weakness” in the context of a known stroke history should trigger a CDI query asking the provider to clarify the type of the original cerebrovascular event. Upgrading from I69.992 to I69.392 when infarction is confirmed improves coding specificity, supports more accurate HCC mapping, and reduces audit vulnerability — and it takes only a single clarifying query to accomplish.
Manifestations & Symptom Burden
- Facial droop / asymmetry — unilateral drooping of the corner of the mouth or cheek, commonly noted on neurological exam and referenced in PT/OT/SLP notes.
- Reduced oral motor control — weakness of the orbicularis oris and buccinator muscles can impair speech articulation and oral phase of swallowing, often co-documented with dysphagia (I69.991).
- Difficulty closing the eye (lagophthalmos) — in central-type facial weakness following CVA, the forehead is typically spared, but incomplete eye closure may still occur and creates risk for corneal exposure injury.
- Drooling / sialorrhea — commonly associated with facial muscle weakness and reduced lip seal; may be documented by nursing or SLP and supports coding of the deficit.
- Psychosocial impact — facial disfigurement from weakness contributes to depression and social withdrawal, which may justify additional coding of F32.x if documented by the treating physician.
Tip
Facial weakness following CVA is a manifestation code under the I69 sequelae framework — it does not require a separate “cause” code to accompany it because the causative event is embedded in the code description itself. However, if the patient is actively being treated for a new acute CVA during the same admission, that acute code should be sequenced first and I69.992 should not be used for the acute-phase facial deficit — I69 codes are for sequelae of past events only, per ICD-10-CM Guideline I.C.9.d.
💰 HCC Risk Adjustment
| Model | HCC Category | HCC Label | RAF Weight (Approximate) |
|---|---|---|---|
| CMS-HCC v28 | HCC 100 | Ischemic or Unspecified Stroke | ~0.240 (community, non-dual) |
| CDPS | Neurological — Moderate | Stroke sequelae | Varies by plan |
| Commercial ACA | N/A | Not applicable for commercial HCC | N/A |
ICD-10 CM I69.992 maps to HCC 100 under CMS-HCC Model v28 when the underlying event is accepted as a cerebrovascular sequela — this is significant for Medicare Advantage plans where chronic condition capture drives annual RAF scoring. Because this is an “unspecified” cerebrovascular code, some payers may challenge the HCC assignment if the original event is not cross-referenced or documented as clinically active and ongoing. Annual recapture of this code in the outpatient setting requires explicit physician documentation each year linking the current facial weakness to the prior CVD event — a one-time past mention is insufficient for MA risk adjustment. Inpatient coders should flag this code for the CDI team when it appears as a secondary diagnosis to ensure the physician’s note includes the language needed for future annual capture.
🏥 MS-DRG Assignment
| Scenario | MS-DRG | Title | Relative Weight (FY2026 approx.) |
|---|---|---|---|
| PDX: I69.992, with MCC | DRG 056 | Degenerative Nervous System Disorders with MCC | ~1.9 |
| PDX: I69.992, with CC | DRG 057 | Degenerative Nervous System Disorders with CC | ~1.2 |
| PDX: I69.992, no CC/MCC | DRG 058 | Degenerative Nervous System Disorders without CC/MCC | ~0.8 |
| SDX: I69.992 (secondary) | N/A — does not function as CC/MCC | — | — |
When I69.992 is the principal diagnosis, the case groups to MDC 01 under the DRG 056-058 family, with payment weight driven entirely by the presence or absence of CC/MCC co-morbidities. Common MCCs in this population include severe malnutrition, sepsis, respiratory failure, and active decompensated heart failure; common CCs include dysphagia (I69.991), hemiplegia (I69.951 / I69.952), and pressure injury staging. As a secondary diagnosis, I69.992 carries no CC/MCC designation and will not independently shift the DRG assignment, but it contributes to the clinical picture for medical necessity and quality of care documentation. Coders should pay close attention to sequencing when the patient is admitted for acute rehabilitation following a prior CVA — in that case, the rehabilitation admission may warrant a Z code as principal with I69.992 as a secondary qualifying diagnosis, depending on payer and facility type.
🔗 Related ICD-10-CM Codes
Same Deficit, Specific CVA Type (Preferred When Documented)
- I69.092 — Facial weakness following nontraumatic subarachnoid hemorrhage
- I69.192 — Facial weakness following nontraumatic intracerebral hemorrhage
- I69.292 — Facial weakness following other nontraumatic intracranial hemorrhage
- I69.392 — Facial weakness following cerebral infarction (most common upgrade target)
- I69.892 — Facial weakness following other cerebrovascular disease
Co-occurring Sequelae and Related Conditions
- I69.991 — Dysphagia following unspecified cerebrovascular disease (frequently coded with I69.992)
- I69.993 — Ataxia following unspecified cerebrovascular disease
- I69.998 — Other sequelae following unspecified cerebrovascular disease
- G51.0 — Bell’s palsy (Excludes 2 — separate etiology, document distinction clearly)
- R29.810 — Facial weakness, unspecified (avoid when cerebrovascular etiology is documented — I69.992 is more specific)
- Z86.73 — Personal history of cerebral infarction without residual deficit
- F32.x — Depressive disorder (may be coded additionally when post-stroke depression is documented by physician)
🛠️ Commonly Associated CPT Codes
- 99223 / 99233 — Initial/subsequent hospital inpatient E&M services — these are the primary professional fee codes billed when a physician evaluates and manages a patient admitted with I69.992 as a principal or significant secondary diagnosis; documentation must support the level of medical decision-making, particularly when facial weakness affects ADLs or is being monitored post-CVA.
- 92610 — Evaluation of oral and pharyngeal swallowing function — frequently ordered when facial weakness co-exists with dysphagia; SLP must document the clinical indication linking swallowing dysfunction to the prior CVA event.
- 97530 — Therapeutic activities, each 15 minutes — billed by physical or occupational therapy for functional training activities directly addressing motor deficits including facial weakness impact on functional tasks; requires physician order and documented functional limitation.
- 92507 — Treatment of speech, language, voice, communication — billed by SLP for oral motor therapy addressing articulation or communication deficits related to facial weakness; must be individualized and medically necessary per documentation.
- 96116 — Neurobehavioral status exam — may be billed when cognitive or neurobehavioral status assessment is performed alongside evaluation of post-CVA deficits including facial weakness; billed by psychologist or neuropsychologist.
NCCI Bundling Considerations
No significant NCCI bundling concerns exist between I69.992 and the CPT codes listed above, as I69.992 is a diagnosis code, not a procedure code, and does not itself trigger procedure-to-procedure edits. However, coders should be alert to bundling edits between 92610 and 92507 when billed on the same date of service by the same provider — SLP evaluation and treatment are subject to NCCI rules and may require modifier -59 or [[-XP]] to indicate distinct services. Therapy CPT codes such as 97530 are time-based and subject to medically unlikely edit (MUE) limits, so accurate unit reporting is essential when facial weakness requires intensive therapeutic intervention.
🔬 ICD-10-PCS Crosswalk
There is no direct ICD-10-PCS procedure code that pairs exclusively with I69.992, but inpatient rehabilitation procedures and neurology interventions may be coded when performed.
- F07Z6ZZ — Speech Treatment, Motor Speech — used when SLP provides direct motor speech treatment targeting articulation deficits caused by facial muscle weakness in the inpatient rehabilitation setting; the root operation and qualifier must reflect the specific treatment approach.
- F06ZYZZ — Speech Assessment, Other — used for formal SLP evaluation of communication deficits including oral motor and facial muscle function in the inpatient setting; may be coded when the evaluation is a separately identifiable billable event under ICD-10-PCS reporting requirements.
💊 Coding Scenarios and Examples
Scenario 1 — Inpatient Admission, PDX Facial Weakness Post-CVA Unspecified A 74-year-old male with a history of a cerebrovascular event (type not documented) presents for inpatient rehabilitation with marked left-sided facial droop, drooling, and articulation difficulty documented by neurology as “facial weakness, sequela of prior CVA.” No acute new event is occurring. Comorbidities include hypertension and type 2 diabetes without complications.
- Correct Coding: I69.992 (PDX), I10 (HTN), E11.9 (DM2)
- Sequencing: I69.992 as principal — this is the condition chiefly responsible for the admission after study.
- CDI Note: Query the neurologist to clarify whether prior CVA was ischemic or hemorrhagic — upgrading to I69.392 improves specificity and HCC capture.
Scenario 2 — Facial Weakness + Dysphagia, Secondary Diagnoses A 68-year-old female admitted for sepsis secondary to aspiration pneumonia. PMH includes unspecified prior CVA with residual facial weakness and dysphagia documented in the H&P by the attending.
- Correct Coding: A41.9 (PDX Sepsis), J18.0 (Aspiration pneumonia), I69.992 (Facial weakness), I69.991 (Dysphagia)
- Sequencing: Sepsis as principal per guideline; aspiration pneumonia as secondary; I69.992 and I69.991 as additional diagnoses supporting clinical complexity.
- CDI Note: Aspiration pneumonia in the context of post-CVA dysphagia supports CDI query for causal linkage, which strengthens MCC/CC burden for DRG optimization.
Scenario 3 — Documentation Conflict, Specificity Upgrade A 79-year-old female’s discharge summary lists “residual facial droop following CVA.” Old records in the chart from an outside facility confirm ischemic stroke two years prior. Coder reviews available documentation.
- Correct Coding: The coder should not self-determine the type of CVA from outside facility records without attending physician confirmation — a CDI query is required. If the attending confirms ischemic stroke, code I69.392; if CVA type cannot be confirmed, I69.992 applies until clarification is obtained.
- Sequencing: Per the condition supporting the current admission.
- CDI Note: This is a classic specificity gap scenario — never assume; always query.
⚠️ Coding Pitfalls and Tips
- Do NOT use I69.992 when the CVA type is documented — if the record anywhere clearly establishes the original cerebrovascular event as an infarction, hemorrhage, or other specified type, the appropriate specificity code (e.g., I69.392) must be used. Using I69.992 when a more specific code applies is a coding error that can trigger payer audits.
- Never code I69.992 for the acute phase — if the patient is experiencing a new, active stroke during this admission, I69 codes do not apply; use the appropriate acute CVA code (I60-I67) and note that sequela coding is for past events with residual deficits.
- Avoid R29.810 when CVA is documented — R29.810 (Facial weakness unspecified) is a symptom code appropriate only when no etiology is established. Once the physician documents that facial weakness is due to prior cerebrovascular disease, I69.992 replaces R29.810 entirely.
- Don’t miss co-existing sequelae — facial weakness frequently coexists with I69.991 (dysphagia), I69.993 (ataxia), and hemiplegia/monoplegia codes. Code all documented deficits — ICD-10-CM guideline I.C.9.d supports assigning multiple I69 codes for the same patient when multiple deficits are present.
- Inpatient rehabilitation sequencing — when I69.992 is the reason for inpatient rehabilitation admission, it should generally be sequenced as the principal diagnosis rather than a secondary; missequencing this code can result in incorrect DRG assignment and potential claim denial.
- Annual recapture for MA plans — remind the CDI and provider teams that for Medicare Advantage patients, I69.992 must be re-documented and re-coded each year to maintain HCC credit; a historical mention alone is insufficient for risk adjustment in the current measurement year.